Fabre N - Search Results

1

Cortical motor overactivation in parkinsonian patients with L-dopa-induced peak-dose dyskinesia.

Rascol O, Sabatini U, Brefel C, Fabre N, Rai S, Senard JM, Celsis P, Viallard G, Montastruc JL, Chollet F. Rascol O, et al. Among authors: fabre n. Brain. 1998 Mar;121 ( Pt 3):527-33. doi: 10.1093/brain/121.3.527. Brain. 1998. PMID: 9549528

2

Naltrexone, an opiate antagonist, fails to modify motor symptoms in patients with Parkinson's disease.

Rascol O, Fabre N, Blin O, Poulik J, Sabatini U, Senard JM, Ané M, Montastruc JL, Rascol A. Rascol O, et al. Among authors: fabre n. Mov Disord. 1994 Jul;9(4):437-40. doi: 10.1002/mds.870090410. Mov Disord. 1994. PMID: 7969211 Clinical Trial.

3

Normal activation of the supplementary motor area in patients with Parkinson's disease undergoing long-term treatment with levodopa.

Rascol O, Sabatini U, Chollet F, Fabre N, Senard JM, Montastruc JL, Celsis P, Marc-Vergnes JP, Rascol A. Rascol O, et al. Among authors: fabre n. J Neurol Neurosurg Psychiatry. 1994 May;57(5):567-71. doi: 10.1136/jnnp.57.5.567. J Neurol Neurosurg Psychiatry. 1994. PMID: 8201325 Free PMC article.

4

The ipsilateral cerebellar hemisphere is overactive during hand movements in akinetic parkinsonian patients.

Rascol O, Sabatini U, Fabre N, Brefel C, Loubinoux I, Celsis P, Senard JM, Montastruc JL, Chollet F. Rascol O, et al. Among authors: fabre n. Brain. 1997 Jan;120 ( Pt 1):103-10. doi: 10.1093/brain/120.1.103. Brain. 1997. PMID: 9055801

5

Normal frontal perfusion in patients with frozen gait.

Fabre N, Brefel C, Sabatini U, Celsis P, Montastruc JL, Chollet F, Rascol O. Fabre N, et al. Mov Disord. 1998 Jul;13(4):677-83. doi: 10.1002/mds.870130412. Mov Disord. 1998. PMID: 9686774

6

Cortical motor reorganization in akinetic patients with Parkinson's disease: a functional MRI study.

Sabatini U, Boulanouar K, Fabre N, Martin F, Carel C, Colonnese C, Bozzao L, Berry I, Montastruc JL, Chollet F, Rascol O. Sabatini U, et al. Among authors: fabre n. Brain. 2000 Feb;123 ( Pt 2):394-403. doi: 10.1093/brain/123.2.394. Brain. 2000. PMID: 10648446

7

Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease.

Rascol O, Arnulf I, Peyro-Saint Paul H, Brefel-Courbon C, Vidailhet M, Thalamas C, Bonnet AM, Descombes S, Bejjani B, Fabre N, Montastruc JL, Agid Y. Rascol O, et al. Among authors: fabre n. Mov Disord. 2001 Jul;16(4):708-13. doi: 10.1002/mds.1143. Mov Disord. 2001. PMID: 11481696 Clinical Trial.

8

Dyskinesia: L-dopa-induced and tardive dyskinesia.

Rascol O, Fabre N. Rascol O, et al. Among authors: fabre n. Clin Neuropharmacol. 2001 Nov-Dec;24(6):313-23. doi: 10.1097/00002826-200111000-00002. Clin Neuropharmacol. 2001. PMID: 11801806 Review.

9

Cortical motor activation in akinetic schizophrenic patients: a pilot functional MRI study.

Payoux P, Boulanouar K, Sarramon C, Fabre N, Descombes S, Galitsky M, Thalamas C, Brefel-Courbon C, Sabatini U, Manelfe C, Chollet F, Schmitt L, Rascol O. Payoux P, et al. Among authors: fabre n. Mov Disord. 2004 Jan;19(1):83-90. doi: 10.1002/mds.10598. Mov Disord. 2004. PMID: 14743365

10

Abnormal vestibuloocular reflex cancellation in multiple system atrophy and progressive supranuclear palsy but not in Parkinson's disease.

Rascol O, Sabatini U, Fabre N, Senard JM, Simonetta-Moreau M, Montastruc JL, Clanet M, Rascol A. Rascol O, et al. Among authors: fabre n. Mov Disord. 1995 Mar;10(2):163-70. doi: 10.1002/mds.870100206. Mov Disord. 1995. PMID: 7753058

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

204 results

Search Page

Filters